Cargando…
Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms
ᅟ: Immunochemical fecal occult blood tests (iFOBTs) are increasingly used for colorectal cancer (CRC) screening. In our preceding observational study, sensitivity for detecting advanced colorectal neoplasms by iFOBT was 70.8% among users of low-dose acetylsalicylic acid compared with 35.9% among non...
Autores principales: | Tikk, Kaja, Czock, David, Haefeli, Walter E., Kopp-Schneider, Annette, Brenner, Hermann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154882/ https://www.ncbi.nlm.nih.gov/pubmed/30249195 http://dx.doi.org/10.1186/s12885-018-4826-3 |
Ejemplares similares
-
Protocol of the VICTORIA study: personalized vitamin D supplementation for reducing or preventing fatigue and enhancing quality of life of patients with colorectal tumor - randomized intervention trial
por: Schöttker, Ben, et al.
Publicado: (2020) -
Prevention of haemoglobin glycation by acetylsalicylic acid (ASA): A new view on old mechanism
por: Ghazanfari-Sarabi, Shabnam, et al.
Publicado: (2019) -
Efficacy and Safety of a Personalized Vitamin D(3) Loading Dose Followed by Daily 2000 IU in Colorectal Cancer Patients with Vitamin D Insufficiency: Interim Analysis of a Randomized Controlled Trial
por: Kuznia, Sabine, et al.
Publicado: (2022) -
Pre-admission acetylsalicylic acid therapy and impact on in-hospital outcome in COVID-19 patients: The ASA-CARE study
por: Sisinni, Antonio, et al.
Publicado: (2021) -
The pattern of epistaxis recurrence in patients taking prophylactic acetylsalicylic acid (ASA) from a 10 year cohort
por: Stanković, Petar, et al.
Publicado: (2022)